{"name":"Revance Therapeutics","permalink":"revance-therapeutics","crunchbase_url":"http://www.crunchbase.com/company/revance-therapeutics","homepage_url":"http://www.revance.com/","blog_url":"","blog_feed_url":"","twitter_username":"","category_code":"biotech","number_of_employees":null,"founded_year":null,"founded_month":null,"founded_day":null,"deadpooled_year":null,"deadpooled_month":null,"deadpooled_day":null,"deadpooled_url":null,"tag_list":"","alias_list":"","email_address":"info@revance.com","phone_number":"(510) 742-3400","description":"Dermatology, Aesthetic Medicine","created_at":"Wed Dec 23 22:49:17 UTC 2009","updated_at":"Sat Jun 11 02:17:42 UTC 2011","overview":"<p>Revance Therapeutics, Inc., a biopharmaceutical company, engages in developing and commercializing products and treatments in dermatology and aesthetic medicines. Its products include RT001, a physician-applied topical botulinum toxin type A (BoNT-A) for cosmetic, hyperhidrosis, and dermatologic indications. The company was formerly known as Essentia Biosystems, Inc. Revance Therapeutics, Inc. was founded in 2002 and is based in Mountain View, California.</p>","image":{"available_sizes":[[[98,36],"assets/images/resized/0007/1055/71055v1-max-150x150.png"],[[98,36],"assets/images/resized/0007/1055/71055v1-max-250x250.png"],[[98,36],"assets/images/resized/0007/1055/71055v1-max-450x450.png"]],"attribution":null},"products":[],"relationships":[{"is_past":false,"title":"Director","person":{"first_name":"Robert","last_name":"Byrnes","permalink":"robert-byrnes","image":null}},{"is_past":false,"title":"Director","person":{"first_name":"Jim","last_name":"Glasheen","permalink":"jim-glasheen","image":null}},{"is_past":false,"title":"Director","person":{"first_name":"Vicente","last_name":"Trelles","permalink":"vicente-trelles","image":null}},{"is_past":false,"title":"Director","person":{"first_name":"Phyllis","last_name":"Gardner","permalink":"phyllis-gardner","image":null}},{"is_past":false,"title":"Director","person":{"first_name":"Frank","last_name":"Kung","permalink":"dr-frank-kung","image":{"available_sizes":[[[107,150],"assets/images/resized/0004/6855/46855v1-max-150x150.jpg"],[[150,210],"assets/images/resized/0004/6855/46855v1-max-250x250.jpg"],[[150,210],"assets/images/resized/0004/6855/46855v1-max-450x450.jpg"]],"attribution":""}}}],"competitions":[],"providerships":[],"total_money_raised":"$70M","funding_rounds":[{"round_code":"d","source_url":"http://www.finsmes.com/2010/01/revance-raises-25m-in-series-d.html","source_description":"Revance Raises $25M in Series D Financing","raised_amount":25000000,"raised_currency_code":"USD","funded_year":2010,"funded_month":1,"funded_day":4,"investments":[{"company":null,"financial_org":{"name":"Essex Woodlands Health Ventures","permalink":"essex-woodlands-health-ventures","image":{"available_sizes":[[[150,22],"assets/images/resized/0005/2525/52525v2-max-150x150.jpg"],[[250,37],"assets/images/resized/0005/2525/52525v2-max-250x250.jpg"],[[306,46],"assets/images/resized/0005/2525/52525v2-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Vivo Ventures","permalink":"vivo-ventures","image":{"available_sizes":[[[150,62],"assets/images/resized/0004/6854/46854v1-max-150x150.png"],[[200,83],"assets/images/resized/0004/6854/46854v1-max-250x250.png"],[[200,83],"assets/images/resized/0004/6854/46854v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Technology Venture Partners","permalink":"technology-venture-partners","image":{"available_sizes":[[[150,26],"assets/images/resized/0001/6360/16360v1-max-150x150.png"],[[250,43],"assets/images/resized/0001/6360/16360v1-max-250x250.png"],[[389,68],"assets/images/resized/0001/6360/16360v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Shepherd Ventures","permalink":"shepherd-ventures","image":{"available_sizes":[[[108,150],"assets/images/resized/0003/0252/30252v1-max-150x150.jpg"],[[146,202],"assets/images/resized/0003/0252/30252v1-max-250x250.jpg"],[[146,202],"assets/images/resized/0003/0252/30252v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Pac-Link","permalink":"pac-link","image":{"available_sizes":[[[143,57],"assets/images/resized/0002/9500/29500v1-max-150x150.png"],[[143,57],"assets/images/resized/0002/9500/29500v1-max-250x250.png"],[[143,57],"assets/images/resized/0002/9500/29500v1-max-450x450.png"]],"attribution":null}},"person":null}]},{"round_code":"unattributed","source_url":"http://www.finsmes.com/2011/06/revance-therapeutics-closes-45m-financing.html?utm_source=feedburner&utm_medium=feed&utm_campaign=Feed%3A+finsmes%2FcNHu+%28FinSMEs%29","source_description":"Revance Therapeutics Closes $45M Financing","raised_amount":45000000,"raised_currency_code":"USD","funded_year":2011,"funded_month":6,"funded_day":10,"investments":[{"company":null,"financial_org":{"name":"Essex Woodlands Health Ventures","permalink":"essex-woodlands-health-ventures","image":{"available_sizes":[[[150,22],"assets/images/resized/0005/2525/52525v2-max-150x150.jpg"],[[250,37],"assets/images/resized/0005/2525/52525v2-max-250x250.jpg"],[[306,46],"assets/images/resized/0005/2525/52525v2-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"NovaQuest","permalink":"novaquest","image":null},"person":null},{"company":null,"financial_org":{"name":"CNF Investments","permalink":"cnf-investments","image":{"available_sizes":[[[150,60],"assets/images/resized/0004/7132/47132v1-max-150x150.png"],[[232,94],"assets/images/resized/0004/7132/47132v1-max-250x250.png"],[[232,94],"assets/images/resized/0004/7132/47132v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Vivo Ventures","permalink":"vivo-ventures","image":{"available_sizes":[[[150,62],"assets/images/resized/0004/6854/46854v1-max-150x150.png"],[[200,83],"assets/images/resized/0004/6854/46854v1-max-250x250.png"],[[200,83],"assets/images/resized/0004/6854/46854v1-max-450x450.png"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Technology Partners","permalink":"technology-partners","image":{"available_sizes":[[[150,63],"assets/images/resized/0003/2706/32706v1-max-150x150.jpg"],[[236,100],"assets/images/resized/0003/2706/32706v1-max-250x250.jpg"],[[236,100],"assets/images/resized/0003/2706/32706v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Shepherd Ventures","permalink":"shepherd-ventures","image":{"available_sizes":[[[108,150],"assets/images/resized/0003/0252/30252v1-max-150x150.jpg"],[[146,202],"assets/images/resized/0003/0252/30252v1-max-250x250.jpg"],[[146,202],"assets/images/resized/0003/0252/30252v1-max-450x450.jpg"]],"attribution":null}},"person":null},{"company":null,"financial_org":{"name":"Palo Alto Investors","permalink":"palo-alto-investors","image":{"available_sizes":[[[150,50],"assets/images/resized/0001/9366/19366v1-max-150x150.png"],[[150,50],"assets/images/resized/0001/9366/19366v1-max-250x250.png"],[[150,50],"assets/images/resized/0001/9366/19366v1-max-450x450.png"]],"attribution":null}},"person":null}]}],"investments":[],"acquisition":null,"acquisitions":[],"offices":[{"description":"","address1":"7555 Gateway Boulevard","address2":"","zip_code":"94560","city":"Newark","state_code":"CA","country_code":"USA","latitude":null,"longitude":null}],"milestones":[],"ipo":null,"video_embeds":[],"screenshots":[{"available_sizes":[[[150,82],"assets/images/resized/0007/1160/71160v1-max-150x150.jpg"],[[250,137],"assets/images/resized/0007/1160/71160v1-max-250x250.jpg"],[[450,246],"assets/images/resized/0007/1160/71160v1-max-450x450.jpg"]],"attribution":null}],"external_links":[]}